Sung Uk Bae1, Se Jin Baek2, Byung Soh Min2, Seung Hyuk Baik2, Nam Kyu Kim2, Hyuk Hur2. 1. Division of Colorectal Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea. 2. Division of Colorectal Surgery, Department of Surgery, Colorectal Cancer Clinic, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Abstract
PURPOSE: Single-port plus one-port, reduced-port laparoscopic surgery (RPLS) may decrease collisions between laparoscopic instruments and the camera in a narrow, bony, pelvic cavity while maintaining the cosmetic advantages of single-incision laparoscopic surgery. The aim of this study is to describe our initial experience with and to assess the feasibility and safety of RPLS for tumor-specific mesorectal excisions (TSMEs) in patients with colorectal cancer. METHODS: Between May 2010 and August 2012, RPLS for TSME was performed in 20 patients with colorectal cancer. A single port with four channels through an umbilical incision and an additional port in the right lower quadrant were used for RPLS. RESULTS: The median operation time was 231 minutes (range, 160-347 minutes), and the estimated blood loss was 100 mL (range, 50-500 mL). We transected the rectum with one laparoscopic stapler in 17 cases (85%). The median time to soft diet was 4 days (range, 3-6 days), and the length of hospital stay was 7 days (range, 5-45 days). The median total number of lymph nodes harvested was 16 (range, 7-36), and circumferential resection margin involvement was found in 1 case (5%). Seven patients (35%) developed postoperative complications, and no mortalities occurred within 30 days. During the median follow-up period of 20 months (range, 12-40 months), liver metastasis occurred in 1 patient 10 months after surgery, and local recurrence was nonexistent. CONCLUSION: RPLS for TSME in patients with colorectal cancer is technically feasible and safe without compromising oncologic safety. However, further studies comparing RPLS with a conventional, laparoscopic low-anterior resection are needed to prove the advantages of the RPLS procedure.
PURPOSE: Single-port plus one-port, reduced-port laparoscopic surgery (RPLS) may decrease collisions between laparoscopic instruments and the camera in a narrow, bony, pelvic cavity while maintaining the cosmetic advantages of single-incision laparoscopic surgery. The aim of this study is to describe our initial experience with and to assess the feasibility and safety of RPLS for tumor-specific mesorectal excisions (TSMEs) in patients with colorectal cancer. METHODS: Between May 2010 and August 2012, RPLS for TSME was performed in 20 patients with colorectal cancer. A single port with four channels through an umbilical incision and an additional port in the right lower quadrant were used for RPLS. RESULTS: The median operation time was 231 minutes (range, 160-347 minutes), and the estimated blood loss was 100 mL (range, 50-500 mL). We transected the rectum with one laparoscopic stapler in 17 cases (85%). The median time to soft diet was 4 days (range, 3-6 days), and the length of hospital stay was 7 days (range, 5-45 days). The median total number of lymph nodes harvested was 16 (range, 7-36), and circumferential resection margin involvement was found in 1 case (5%). Seven patients (35%) developed postoperative complications, and no mortalities occurred within 30 days. During the median follow-up period of 20 months (range, 12-40 months), liver metastasis occurred in 1 patient 10 months after surgery, and local recurrence was nonexistent. CONCLUSION: RPLS for TSME in patients with colorectal cancer is technically feasible and safe without compromising oncologic safety. However, further studies comparing RPLS with a conventional, laparoscopic low-anterior resection are needed to prove the advantages of the RPLS procedure.
Authors: M Buunen; H J Bonjer; W C J Hop; E Haglind; G Kurlberg; J Rosenberg; A M Lacy; M A Cuesta; A D'Hoore; A Fürst; J F Lange; P Jess; O Bulut; P Poornoroozy; K Juul Jensen; M Mark Christensen; E Lundhus; H Ovesen; D Birch; I Iesalnieks; C Jäger; M Kreis; Y van riet; E van der Harst; M F Gerhards; W A Bemelman; B M E Hansson; P A Neijenhuis; H A Prins; C Balague; E Targarona; J A Luján Mompeán; J D Franco Osorio; F J Garcia Molina; S Skullman; Z Läckberg; U Kressner; P Matthiessen; S H Kim; A Alfredo Poza Journal: Dan Med Bull Date: 2009-05
Authors: David G Jayne; Pierre J Guillou; Helen Thorpe; Philip Quirke; Joanne Copeland; Adrian M H Smith; Richard M Heath; Julia M Brown Journal: J Clin Oncol Date: 2007-07-20 Impact factor: 44.544
Authors: Peter Tschann; Gerald Seitinger; Daniel Lechner; Stephanie Adler; Benedikt Feurstein; Paolo N C Girotti; Theresa Schmölzer; Philipp Szeverinski; Felix Aigner; Ingmar Königsrainer Journal: Int J Colorectal Dis Date: 2021-04-06 Impact factor: 2.571
Authors: Deborah S Keller; Juan R Flores-Gonzalez; Jaideep Sandhu; Sergio Ibarra; Nisreen Madhoun; Eric M Haas Journal: J Gastrointest Surg Date: 2015-08-18 Impact factor: 3.452
Authors: Ji Hoon Kang; Soo Young Lee; Chang Hyun Kim; Hyeong Rok Kim; Han Deok Kwak; Jae Kyun Ju; Young Jin Kim Journal: Ann Surg Treat Res Date: 2018-02-28 Impact factor: 1.859